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Autoregulation of NFATc1/A Expression Facilitates
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I. Their stimulation by CD95 ligand or TNF leads to theThreshold levels of individual NFAT factors appear to
activation of a caspase cascade and, in turn, to cleavagebe critical for apoptosis induction in effector T cells.
of death substrates and, finally, to apoptosis of T cellsIn these cells, the short isoform A of NFATc1 is induced
(see, e.g., Schmitz et al., 2000). Both the CD95 ligandto high levels due to the autoregulation of the NFATc1
and TNF promoter contain multiple NFAT sites (Falvopromoter P1 by NFATs. P1 is located within a CpG
et al., 2000; Li-Weber et al., 1999), suggesting thatisland in front of exon 1, represents a DNase I hyper-
NFATs are major regulators of AICD of T cells.sensitive chromatin site, and harbors several sites for
NFATc1 and NFATc2 share 72% sequence homologybinding of inducible transcription factors, including a
in their RSDs and act similarly in functional assays. How-tandemly arranged NFAT site. A second promoter, P2,
ever, inactivation of either of the two genes resulted inbefore exon 2, is not controlled by NFATs and directs
markedly divergent mutant phenotypes. Due to defectssynthesis of the longer NFATc1/BC isoforms. Con-
in the development of cardiac valves and septa,trary to other NFATs, NFATc1/A is unable to promote
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acids (aa). This domain is very similar in its conformation due to an impaired expression of CD95 ligand (Hodge
to the Rel DNA binding domain of Rel/NF-B factors et al., 1996). This phenotype was found to be accelerated
and, therefore, was designated as Rel similarity domain in mice deficient for both NFATc2 and NFATc3 (Ranger
(RSD; for reviews see Rao et al., 1997; Serfling et al., et al., 1998c). In contrast, peripheral NFATc1/ T cells
2000). Among the four genuine NFAT factors, NFATc1, from RAG/ mice show an impaired proliferation but
NFATc2, NFATc3, and NFATc4, the RSDs exhibit ap- no apparent defects in apoptosis (Ranger et al., 1998b;
proximately 70% sequence homology and about 40% Yoshida et al., 1998). Lymphocytes doubly deficient for
with a fifth protein, designated as NFAT5 (Lopez-Rodri- NFATc1 and NFATc2 exhibit a complete loss of IL-2 and
guez et al., 1999). The nuclear translocation of genuine IL-4 production but—similar to NFATc2/ lympho-
NFAT factors but not of NFAT5 is regulated by the Ca2/ cytes—a hyperproliferative syndrome which is charac-
terized by high IgG1 and IgE serum levels and an in-
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cellular threshold levels for both factors also determine and C-terminal peptides. The short NFATc1/A isoform
(Northrop et al., 1994) is predominantly expressed in Twhich set of target genes will be expressed. We have
shown previously that T cell activation leads to the mas- effector cells and lacks the BC-specific C-terminal
peptide sequences that are encoded in exons 10 andsive induction of the short isoform A of NFATc1 within
3–4 hr (Chuvpilo et al., 1999b), i.e., before the onset of 11 (Chuvpilo et al., 1999b). They share 31% sequence
homology with the C-terminal peptide of murine NFATc2AICD. This observation suggested that, due to the lack
of the C-terminal extension of approximately 245 aa (Luo et al., 1996a). Similar to the generation of human
NFATc1 isoforms, the synthesis of murine NFATc1 iso-which is present in all other NFAT proteins, NFATc1/A
might differ in biological function from other NFAT pro- forms is controlled by the activity of (at least) two poly
A sites located downstream of exon 9 (pA1) and exonteins, including its longer isoform NFATc1/C. This view
prompted us to investigate the induction and function 11 (pA2), respectively (see Figure 1B).
The transcription of both the human and murineof NFATc1/A in murine T lymphocytes.
Here we show that the induction of NFATc1/A in ef- NFATc1 gene results in two RNAs containing different
5 ends. The most abundant NFATc1 RNA, designatedfector T cells is controlled by a strong inducible pro-
moter, P1. It results in splicing of exon 1 to exon 3 as NFATc1. (Park et al., 1996), codes for an N-terminal
peptide of 42 aa which is missing in a minor RNA fraction,transcripts and, in concert with the activity of a weak
poly A site downstream of exon 9 (Chuvpilo et al., 1999b), designated as NFATc1.. This encodes a unique N-ter-
minal peptide of 29 or 27 aa in human or mouse, respec-leads to the massive synthesis of NFATc1/A in effector
T cells. A second, weak promoter, P2, lies in front of tively (Chuvpilo et al., 1999b; Park et al., 1996; Sherman
et al., 1999). These findings and the structure of NFATc1exon 2 and directs the synthesis of longer NFAT isoforms
B and C. Both P1 and P2 generate DNase I hypersensi- 5 region suggest that NFATc1 RNAs are synthesized
from two promoters and by alternate splicing eventstive chromatin sites and are embedded in CpG islands
which are hypermethylated in nonlymphoid cells and (Serfling et al., 2000).
demethylated in effector T cells. P1 but not P2 activity
is autoregulated by NFAT factors which bind with high NFATc1 Transcription Is Controlled by Two Promoters
affinity to two tandemly arranged NFAT sites within P1 The 5 region of murine NFATc1 gene (Figure 1C) which
and enhance its induction. Infection of primary T lym- we cloned as an XbaI fragment of 8650 bp contains the
phocytes with recombinant retroviruses expressing indi- most distal exon 1, encoding the 42 aa of NFATc1.,
vidual NFAT proteins indicates that NFATc1/A, in con- and exon 2, encoding the 27 aa in NFATc1.. Exons 1
trast to NFATc2 and NFATc1/C, does not enhance AICD. and 2 are separated from each other by an intron of
These findings suggest that the massive synthesis of approximately 4 kb. Conspicuous sequence character-
NFATc1/A upon activation of effector T cells ensures istics are 375 CpG dinucleotides, i.e., potential targets
that these cells exert effector functions without inducing for DNA methylation, which are clustered around the
rapid apoptosis. transcriptional start sites and within the 5 untranslated
mRNA regions (Figure 1D). Sequence features within
Results intron 1 are a stretch of 160 pyrimidines, ten copies of
the pentanucleotide CTTTT, and a sequence of 40 bp
Induction of NFATc1/A in T Cells that is 87.5% identical to a sequence within intron 1 of
Activation of human Jurkat T cells (Figure 1A) or human the murine whn nude gene that is also controlled by two
and murine primary effector T cells by TPAionomycin promoters and alternate splicing events (Schorpp et al.,
(TI) or by CD3CD28 Abs (see Chuvpilo et al., 1997). In addition, approximately 430 bp downstream
1999a, 1999b) for 4 hr or longer led to a strong induction from exon 2, an integration sequence was detected for
of synthesis of the short NFATc1 isoform A while the the retrovirus SL3-3, a potent inducer of T cell lympho-
synthesis of the other NFATc1 isoforms and of NFATc2 mas in mice (Sorensen et al., 1996).
remained unaffected (Figure 1A). The massive induction Depending on the activity of the two promoters, desig-
of NFATc1/A was completely suppressed by 100 ng/ml nated as P1 and P2, NFATc1 transcription starts up-
CsA which selectively inhibits NFAT factors, suggesting stream of exon 1 and exon 2, respectively. In RNase
that NFATs autocontrol the inducible transcription of mapping assays, using RNA from EL-4 T cells and M12
NFATc1/A. This prompted us, first, to identify the B cells and an exon 1-specific probe, a strong, inducible
NFATc1 promoter region and analyze its activity, and P1 activity was detected in both cell types. In contrast,
second, to study the role of NFATc1/A in effector T cells P2 activity was observed in EL-4 but not M12 cells (Fig-
where it is strongly induced. ure 2A; P2). Moreover, P2 activity was found to be mark-
edly weaker, reaching about 5% of P1 activity. In EL-4
cells, P1 activity was induced by T or I alone, and TIStructure of the Chromosomal Murine NFATc1 Gene:
Alternative Splicing and Polyadenylation Events double treatment enhanced P1 induction, which could
be abolished by CsA. Forskolin (F) treatment which en-Contribute to Its Expression
The murine NFATc1 gene which we have cloned as over- hances cAMP levels and upregulates the expression of
Th2-type NFAT target genes, e.g., IL-5, exerted a verylapping DNA fragments in BAC, cosmid, and  vectors
is located on chromosome 18 band E4 (Li et al., 1995) weak stimulatory effect on P1, either alone or in combi-
nation with ionomycin, and it impaired TI-mediated P1and consists of 11 exons that are spread over more than
100 kb DNA (Figure 1B). Similar to the human NFATc1 induction (Figure 2B).
A single start point situated 53 bp in front of the firstgene (see Serfling et al., 2000), the murine gene is ex-
pressed in several isoforms which differ both in their N- translational start codon is used for transcription from
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Figure 1. NFATc1/A Induction, Structure of the Murine Chromosomal NFATc1 Gene, and Its Promoter Region
(A) NFATc1/A induction in Jurkat T cells. Western blot with whole cellular proteins from Jurkat cells which were either left untreated (; lane
1) or treated with TPAionomycin (TI) in the absence or presence of 100 ng/ml CsA for 2 or 4 hr.
(B) Schematic structure of the NFATc1 gene. The lengths of 11 exons in bp is indicated above the gene. White numbers in black fields indicate
the lengths of 5 and 3 untranslated mRNA regions; black numbers indicate the lengths of protein coding segments. The positions of promoters
P1 and P2 and poly A sites pA1 and pA2 are indicated.
(C) Structure of the 8.65 Kb XbaI DNA fragment harboring the two promoters P1 and P2. The protein coding portions of exons 1 and 2 are
indicated by dashed boxes, and their 5 untranslated mRNA regions are indicated by thick black bars. Horizontal arrows before both 5 mRNA
regions indicate the promoters P1 and P2. Conspicuous sequence motifs are a stretch of 40 bp which is found in several other genes
alternatively spliced at their 5 ends (see Schorpp et al., 1997), a stretch of 160 pyrimidines, ten copies of sequence CTTTT, and an integration
sequence for the retrovirus SL3-3, a potent inducer of T cell lymphomas (Sorensen et al., 1996).
(D) Distribution of CpG residues within the promoter region. Above, one vertical dash indicates one CpG residue. The graph below shows the
distribution of 375 bp CpGs within 500 bp intervals of the XbaI fragment.
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Figure 2. Detection of NFATc1 RNA in Lymphoid and Nonlymphoid Cells and RNase Mapping Assays
(A) Detection of transcripts directed from the NFATc1 promoters P1 and P2 in EL-4 T and M12 B cells. Probes for the detection of exon 1
transcripts (P1) and of transcriptional start site at P2 were hybridized with whole RNA from EL-4 T cells (lanes 1–3) and M12 B cells (lanes
4–6) which were either left uninduced () or induced by TPA and ionomycin for 1 or 4 hr. In lanes 7–12, the P2 probe was used alone.
(B) P1 induction. RNAs from EL-4 cells induced for 1 hr by TPA (T), ionomycin (I), or forskolin (F) alone or in combination were investigated.
In lane 9, cells were induced by TI in the presence of 100 ng/ml cyclosporin A (CsA).
(C) Mapping of the transcriptional start sites at P1. A probe recognizing upstream start sites of exon 1 transcription was hybridized with 5
	g of RNA from naive T cells, Th0, Th1, and Th2 cells, or EL-4 cells. The primary Th cells were induced by CD3CD28 Abs and EL-4 cells
by TI for the times indicated.
(D) Detection of P1 activity in various hematopoietic cells. An exon 1 probe (P1) was hybridized with 5 	g (Th cells) or 10 	g RNA from various
cells which were either left uninduced or induced for 1–48 hr by TI. Primary mast cells were induced for 12 hr by I, IL-1, and IL-10 as
published previously (Stassen et al., 2000). The position of exon 1 transcripts is indicated. P, undigested probes.
(E) Detection of P1 activity in various murine cells. An exon 1 probe was hybridized with 10 	g RNA from EL-4 T cells, embryonic stem (ES)
cells, F9 embryonic carcinoma (EC) cells, L fibroblast, NIH 3T3 cells, HL-1 heart cells, and N2A nerve cells, which were either left uninduced
or treated by TI for 1 or 4 hr.
P2, while two transcriptional start points are used for lines (such as in 70 Z pre B cells, WEHI 231, M12, TIB
209, and A20J B cells) treated with TI for 1–4 hr, andtranscription directed by P1. These are located 315 and
255 bp upstream of the first ATG and appear to be used in NK cells. P1-directed transcripts were also detected
in primary mast cells stimulated with IL-1 and IL-10 foralternatively. As shown in Figure 2C, the distal site, P1dist,
is used after induction of naive T cells, Th1, and Th2 12 hr, and in CP2 cells, a mast cell line (Figure 2D and
data not shown) which agrees well with a role of NFATscells, whereas the P1prox site is predominantly used in
naive Th and Th1 but not Th2 cells. in regulating lymphokine expression in mast cells
(Prieschl et al., 1995). None or at most a very weak P1-P1-directed transcription was detected in all activated
lymphoid cells investigated. In addition to transcription directed transcription was observed in P388 D1 mono-
cytes (Figure 2D) and in all other nonlymphoid cells in-in EL-4 cells, it was found in naive primary T cells from
LNs activated by CD3CD28 Abs for 24 hr or 48 hr, vestigated, such as in embryonic stem (ES) cells (line
WW6), F9 embryonic carcinoma (EC) cells, L cells, 3T3in Th1 and Th2 cells activated for 2 hr, in several B cells
Autoregulation of NFATc1 and Apoptosis
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Figure 3. Mapping of DNase I Hypersensitive Chromatin Sites within the Promoter Region of the NFATc1 Gene and Characterization of an
Intronic Transcriptional Enhancer
(A and B) EL-4 T cells and naive lymph node (LN) cells which were either left uninduced () or induced for 1 hr (EL-4, ) by TPAionomycin
or 5 hr (LN) by CD3/CD28 Abs. Nuclei from 108 cells were either left untreated or treated with increasing concentrations of DNase I. After
extraction, the DNAs were digested with XbaI and, following Southern blotting, hybridized with PCR probes from the 3 end (A; left autoradio-
graph) or the 5 end (B; right) of the 8.65 kb XbaI promoter fragment. Below, the length of DNA fragments generated after partial DNase I
cleavage is presented.
(C) Characterization of an intronic enhancer. Segments of 1 kb (HSS3) and 0.6 kb (HSS3core) from the HSS3 region of intron 1 were cloned in
two orientations in front of the 0.8 kb P1 promoter in a P1-luciferase construct. EL-4 cells were transfected and treated as indicated for 24 hr.
cells, HL-1 cardiomyocytes, and N2A neuronal cells HSS1-HSS4) were mapped over the 5 region of the
NFATc1 gene. HSS1 and HSS4 are located over the P1treated with TI for 1 or 4 hr (Figure 2E).
and P2 promoters, HSS2 and HSS3, within intron 1.
HSS2 is situated just downstream from exon 1 whereasDNase I Hypersensitive Chromatin Sites Are
Generated at the P1 and P2 Promoters HSS3 covers the 40 bp “common” and 160 bp pyrimidine
DNA stretches (Figures 3A and 3B). All these sites ap-and Two Intronic Sites
Irrespective of the activation state of EL-4 cells, four peared to be quite resistant against DNase I in chroma-
tin from primary naive LN cells, but stimulation byDNase I hypersensitive chromatin sites (designated as
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Figure 4. P1 Promoter DNA Is Demethylated in T Effector Cells
(A) DNA sequences of immediate P1 region from murine effector T cells (above) and kidney cells (below) after Na-bisulfite modification for
the detection of methylated CpG residues. Note the methylation of all seven CpG residues in kidney DNA but not in DNA from effector T cells.
As controls, the methylation profiles of nonmethylated control DNA (indicated by  in the inset above) and DNA methylated in vitro with SssI
DNA methylase ( in the inset above) are shown between.
(B) Methylation of P1 DNA supresses its activity. P1 DNA segments of 0.8 and 1.7 kb were methylated in vitro using SssI methylase, cloned,
and transfected into EL-4 cells. After 24 hr, the cells were either left untreated or treated by TPAionomycin (TI) or ionomycinforskolin
(IF) for an additional 24 hr. In the inset, the patterns of 1.7 kb (lanes 3–6) or 0.8 kb P1 fragments (lanes 9–12) after cleavage with the restriction
enzymes HpaII (H) or MspI (M) are shown. In lanes 1 and 7, high molecular (LHM) or low molecular weight marker DNAs (LHM) and, in lanes 2
and 8, the uncleaved DNA fragments of 1.7 or 0.8 kb, respectively, were separated. Lanes 3, 4, 9, and 10 contain nonmethylated DNAs; lanes
5, 6, 11, and 12 contain DNAs methylated by SssI in vitro.
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Figure 5. Induction Properties of NFATc1 P1
Promoter in EL-4 Cells
(A) Characterization of the P1 core promoter.
Luciferase gene constructs directed by P1
segments of 0.8, 1.7, 2.7, or 5.5 kb were trans-
fected into EL-4 cells. After 24 hr, the cells
were treated with TPA (T), ionomycin (I), or
forskolin (F) alone or in combination for an
additional 24 hr in the absence or presence
of cyclosporin A (CsA).
(B) Induction properties of murine IL-2, IL-4,
and IL-5 promoters in EL-4 cells. Luciferase
genes directed by the murine IL-2 promoter
(spanning the nucleotides from position 7
to293), IL-4 promoter (12 to270), or IL-5
promoter (44 to507) were transfected into
EL-4 cells which were induced for 24 hr as
indicated.
CD3CD28 Abs led to a rapid generation of sensitiv- to370 were found to be methylated in genomic kidney
DNA whereas they were unmethylated within genomicity over P1 and P2 within 5 hr (Figure 3B). In chromatin
from F9 EC cells, these sites seem to be closed since P1 DNA from effector T cells. In order to show whether
DNA methylation might affect P1 induction, P1 frag-partial DNase I digestion of chromatin from these cells
did not give rise to any DNA fragmentation, regardless ments of 0.8 kb and 1.7 kb were isolated and methylated
in vitro using bacterial SssI methylase. As shown in theof whether or not they were treated with TI (data not
shown). insert of Figure 4B, by cleavage of fragments with HpaII
or MspI, SssI led to a complete methylation of all CCGGIn order to investigate whether the intronic HSS2 and
HSS3 sites play a role in P1 activity, fragments spanning recognition motifs for both enzymes. When the methyl-
ated and nonmethylated promoter fragments wereeither HSS2 or HSS3 were cloned in both orientations
in front of a promoter/luciferase gene driven by the 0.8 tested in EL-4 cells, a 5-fold decrease in the IF-medi-
ated activity was detected for methylated P1 DNA com-kb P1 core promoter and tested by transfection into
EL-4 cells. While no effect on P1 induction was observed pared to nonmethylated control DNA (Figure 4B). This
indicates that DNA methylation can suppress P1 in-for the HSS2 fragment (data not shown), HSS3 frag-
ments of 1 or 0.6 kb DNA enhanced P1 induction in both duction.
orientations 2- to 10-fold (Figure 3C). Hence, HSS3 was
designated as transcriptional enhancer, E1. As for P1
(see below), the strongest induction of E1 was observed NFATs Autoregulate P1 Induction and Enhance
after treatment of cells with a combination of IF, NFATc1/A Synthesis
whereas a very poor induction was detected after TI When 5 P1 segments spanning 0.8, 1.7, 2.7, or 5.5 kb
treatment. In particular, the F-mediated induction of P1 of upstream DNA were tested in EL-4 cells, all fragments
was enhanced by E1 from about 5- to more than 50- showed a similar transcriptional activity (Figure 5A). This
fold (Figure 3C). indicates that the proximal segment of 0.8 kb harbors
the most important promoter elements and, therefore,
was designated as P1 core promoter. P1 activity wasDNA Hypomethylation Facilitates P1 Induction
induced by F but markedly less by T or I alone. A combi-in T Effector Cells
nation of IF, i.e., by inducers of Ca2-involved signalingThe distribution of CpG dinucleotides within the NFATc1
cascades or protein kinase A, resulted in a strong syner-5 region (Figure 1D) suggested that DNA methylation
gistic activation of P1 whereas TI induction was mark-might play an important role in the regulation of NFATc1
edly less efficient (Figure 5A), contrary to its strong effectpromoters. To correlate the methylation status of P1
on the P1 promoter in its chromosomal context (FigureDNA with its activity, DNA from various cell types was
2B). This is also in striking contrast to the induction ofisolated, and genomic P1 DNA was sequenced following
the IL-2 promoter in EL-4 cells whose activity is stronglymodification with Na-bisulfite which converts unmethyl-
induced by TI but not by IF or F alone. However, itated but not methylated C to T residues (Frommer et
resembles the induction of promoters of the Th2-typeal., 1992). As illustrated in Figure 4A for a fragment of P1
DNA, CpG residues spanning the nucleotides from 61 lymphokines IL-4 and IL-5, the activity of which is
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Figure 6. Structure of P1 Promoter and Its Autoregulation by NFAT Factors
(A) P1 sequences are highly conserved between the human and murine NFATc1 genes. Transcriptional start sites are indicated by horizontal
arrows; binding sites for transcription factors are indicated by black bars above the sequences. Brackets above the sequences indicate the
oligonucleotides used in EMSAs for the identification of transcription factors binding.
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strongly induced by IF but weakly by TI treatment ure 6B), (2) an excess of P1 NFATtand site with intact
NFAT motifs but not of a site mutated in both NFATin EL-4 cells (Figure 5B).
Two DNA segments of approximately 270 bp from the motifs suppressed factor binding (lanes 4 and 5), and
(3) Abs specific for NFATc1 or NFATc2 led to supershiftsP1 core promoter spanning the nucleotides from 25
to 250 and from 520 to 800 show more than 80% of NFATtand complexes (lanes 9 and 10), NFATtand is a
genuine NFAT binding site. Compared to the NFAT90sequence homology between mouse and human (Figure
6A). The proximal homology block contains two con- site of P1 (see also Zhou et al., 2002) and to Pu-bd of
IL-2 promoter, NFATtand is a stronger NFAT binding siteserved (TATA-like?) boxes located around 15 and 30 bp
upstream of the distal transcriptional start site, several (note that the EMSA probes used in Figure 6B were
of about the same specific radioactivity). According toGC rich stretches, and, in addition, the sequences
TGATGTCA and TTTTCCA located within larger stretches supershift assays, the NFATtand complexes exhibiting the
slowest and fastest mobility contain NFATc1 whereasof high sequence homology. The latter motif located
around position 90 corresponds to a NFAT consensus complexes with intermediary mobility contain NFATc2
(lanes 9 and 10 in Figure 6B). Both types of complexessite (see below and Figure 6B), the former to a CREB
consensus binding sequence (see below). We will show are also formed with Pu-bd and the NFAT90 site.
Contrary to P1, the activity of P2 is not regulated byin detail elsewhere (D.T. et al., unpublished data) that
the GC-rich motifs around positions 200 and 20 NFAT factors. The inability of P2 oligonucleotides to
compete for the generation of NFAT complexes (Figureare bound by SP1SP3 and the CREB-like motif TGAT-
GTCA around position 145 by CREB, Fos, and ATF-2 6C) and missing NFAT binding motifs indicate that NFAT
factors do not bind to P2.proteins. A similar CREB binding site was detected
around position 640 within the distal block of homol- The configuration of tandemly arranged TGGAAAA
NFAT core sequences at NFATtand led to the question ofogy and might contribute, along with the proximal site,
to the strong effect of elevated cAMP levels on P1 induc- whether, contrary to a typical NFAT site which is bound
by monomeric NFAT and AP-1, NFAT dimers can bindtion. In addition, this distal P1 fragment is also bound by
NF-B, NFAT, and, with low affinity, by GATA-3 protein to NFATtand. When we incubated mutated NFATtand sites
which should suppress NFAT binding to one or the other(Figure 6A).
Within P1 DNA upstream of position 250, there are NFAT core motif in EMSA titration experiments with in-
creasing concentrations of bacterially expressed GST-four additional consensus sequences for the binding of
NFAT factors. However, only two of them, which are NFATc1-RSD protein, a very similar complex formation
was observed with the wild-type or mutated probes. Atandemly arranged around position 675, formed spe-
cific NFAT factor complexes when they were incubated probe mutated in both motifs did not bind any GST-
NFATc1-RSD protein (Figure 6D). However, dimer for-with GST-NFATc1-protein in EMSAs (data not shown).
When a probe spanning the tandem sites (NFATtand) was mation, i.e., the binding of two NFAT proteins to one
NFATtand probe, was observed when we introduced 5 orincubated with nuclear proteins from EL-4 cells, several
prominent inducible protein complexes were generated 10 bp between both NFAT motifs. This is shown in Figure
6E where dimer formation could be observed with awhich were very similar in mobility to those generated
with the distal NFAT site (Pu-bd) of the IL-2 promoter, NFATtand5n or NFATtand10n probe whereas no dimer for-
mation was detected with the distal IL-2 NFAT site (Fig-the prototypical NFAT site (compare lanes 2 and 17 in
Figure 6B). Since (1) an excess of distal IL-2 NFAT site ure 6E).
The importance of NFAT activity in P1 induction issuppressed NFAT binding to NFATtand (see lane 8 in Fig-
(B) NFAT-like complexes bind to the NFATtand and NFAT90 sites of P1. Nuclear proteins from noninduced EL-4 cells (lanes 1, 11, and 16) or
cells treated with TI for 1 hr in the absence (lanes 2, 4–10, 12, 14, 15, and 17–19) or presence of 100 ng/ml CsA (lanes 3 and 13) were
incubated with an NFATtand, NFAT90, or IL-2 NFAT (Pu-bd) probe. For competition, 50 ng of a wild-type NFATtand site (lane 4), a mutated NFATtand
site unable to bind NFAT (lane 5), a wild-type NFAT90 site (lane 6), a mutated NFAT90 site (lane 7), or an IL-2 Pu-bd site (lane 8) was added.
Abs raised against NFATc1 (lanes 9, 14, and 18) or NFATc2 (lanes 10, 15, and 19) were used in supershift assays.
(C) NFATs do not bind to P2. Nuclear proteins from noninduced EL-4 cells (lane 1) or EL-4 cells treated by TI for 1 hr (, lanes 2–8) were
incubated with an NFATtand probe and 5 or 50 ng of IL-2 NFAT site or oligos spanning the nucleotides from position 107 to 142 (P2-1)
or 72 to 107 from P2 (P2-2).
(D) NFATc1 can bind to each of both NFAT core motifs within the NFATtand element. Increasing concentrations of GST-NFATc1-RSD protein
were incubated with a wild-type NFATtand probe or probes mutated in one of two or both NFAT motifs.
(E) Introduction of 5 or 10 spacer bp between the NFAT core motif leads to the generation of NFAT dimers. Increasing concentrations of GST-
NFATc1-RSD protein were incubated with probes carrying 5 or 10 spacer nucleotides between the two NFAT motifs or an IL-2 NFAT site
probe.
(F) Introduction of NFAT mutations into NFATtand abolish P1 induction. Two micrograms DNA of luciferase constructs driven by wild-type (wt)
P1 or a P1 fragment mutated in both NFAT sites of NFATtand (d-mut) was transfected into EL-4 cells which were either left untreated (–) or
treated by TI or IF.
(G) Ectopic expression of NFATc2 or NFATc1/A in EL-4 cells enhances P1 activity. 0.2 micrograms of a P1-directed luciferase construct was
transfected into EL-4 cells either with 0.5 	g empty vector DNA () or vectors expressing NFATc2 or NFATc1/A.
(H) Ectopic expression of NFATc proteins in 293 HEK cells enhances P1 activity. One hundred nanograms of a P1-directed luciferase construct
was transfected into 293 cells either with 100 or 250 ng vector DNA (–) or the same amounts of vectors expressing NFATc1/A, NFATc1/C, or
NFATc2. The inset shows the expression of NFAT proteins detected with an HA-Ab in a Western immunoblot.
(I) NFATc1 protein expression leads to a more persistent induction of endogenous P1 activity. RNAs from EL-4 cells stably infected with an
empty virus (–) or viruses expressing NFATc1/A or c1/C and treated for 0–24 hr with TI were assayed in RNase protein assays using probes
to detect P1 or GAPDH transcripts. Above, the rate of P1 induction is indicated.
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Figure 7. In Contrast to NFATc2 and NFATc1/C, NFATc1/A Is Unable to Promote Apoptosis of Effector T Cells
(A) NFATc2-deficient T cells show a delay in CD3-mediated apoptosis. CD4 T cells from lymph nodes of wild-type or NFATc2/ mice were
either restimuated by incubation with an CD3
 mAb or an CD95 mAb for 6 hr (green lines), 12 hr (orange), 24 hr (blue), or 48 hr (red).
(B) Effect of ectopic NFAT expression on CD3-mediated apoptosis. Twenty-four hours after stimulation with OVA peptide, CD4 T cells from
DO 11.10 TCR tg mice were infected with an empty retrovirus (EGZ-HA) or retroviruses expressing NFATc1/A or NFATc2. After 3 days of
expansion, the cells were either left untreated or restimulated with plate-bound CD3
 mAb for 8 hr, stained with annexin V-PE, and analyzed
by FACS.
(C) NFATc2 and NFATc1/C but not NFATc1/A enhance CD3
 mAb-mediated apoptosis. The percentage of annexin V-positive cells is shown
from noninfected cells () and cells infected with the control virus pEGZ-HA or NFAT-expressing retroviruses. Compilation of data from four
independent experiments.
(D) Detection of ectopic NFAT expression in primary T cells. Three days after infection of CD4 T cells from DO 11.10 TCR tg mice with control
virus (pEGZ-HA, lane 1,  and ) or virus-expressing NFATc1/A (lane 2), NFATc1/C (lane 3), or NFATc2 (lane 4), the cells were either left
uninduced () or induced with plate-bound CD3
 mAb for 3 hr (). Nuclear proteins from infected cells were prepared and assayed in
Western blots using an HA Ab or, as loading control, a -actin-specific Ab.
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Figure 8. Model of Transcription of Murine NFATc1 Gene in T Cells
The transcription of NFATc1 gene is controlled by two promoters, P1 and P2, and two poly A sites, pA1 and pA2. The highly inducible
transcription of the short isoform NFATc1/A in effector T cells is always controlled by the strong promoter P1 and the weak poly A site pA1
(see Chuvpilo et al., 1999b). The synthesis of the longer isoforms NFATc1/B and C is controlled by either P1 or P2 and by the strong poly A
site pA2. The autoregulation of P1 promoter by NFAT factors results in an increase of NFATc1/A but not NFATc1/BC synthesis.
demonstrated by introducing mutations into P1 at the 1998; Ranger et al., 1998c). This is shown in Figure 7A
where a marked delay in AICD induction of peripheralNFATtand site which suppress NFAT binding and by co-
transfections of a P1-directed luciferase reporter gene T cells from NFATc2-deficient mice can be seen after
treatment with CD3 Abs. Since NFATc1-deficient T cellsinto EL-4 and 293 cells with vectors expressing NFATc
proteins. As shown in Figure 6F, mutation of both NFAT are difficult to obtain due to the embryonic lethality of
NFATc1/ mice, we transduced primary murine CD4 Tsites abolished any P1 activity. In cotransfections, ec-
topic NFATc2 expression resulted in a 2- to 3-fold in- cells from DO11.10 TCR tg Balb/c mice (Murphy et al.,
1990) with retroviruses expressing NFATc1/A, NFATc1/C,crease and NFATc1/A expression in a 4- to 5-fold in-
crease in inducible P1 activity in EL-4 cells which or NFATc2. After primary stimulation with the corre-
sponding Ova peptide and APCs, the cells were ex-express relatively high levels of endogenous NFAT (Fig-
ure 6G). In 293 HEK cells which express minute amounts panded for 3 days, and AICD was induced by incubation
of cells for 8 hr with plate-bound CD3 Abs. Transduc-of endogenous NFATs, a stronger increase in P1 activity
was observed after cotransfections with vectors ex- tion of primary T cells with “empty” control virus or
virus expressing-NFATc1/A led to an infection efficiencypressing NFATc1/A or c1/C (Figure 6H).
Expression of NFAT proteins in EL-4 cells exerts a between 20%–50% (measured by EGFP expression;
Figure 7B), and the infected cells showed a spontaneousmoderate but measurable stimulatory effect on the ex-
pression of endogenous NFAT target genes, e.g., of apoptosis rate of approximately 10% after 3 days of
expansion, very similar to noninfected cells. In contrast,the IL-2, IL-4, and IL-5 genes (our unpublished data). A
similar increase was detected when we measured the T cells transduced with viruses expressing either
NFATc2 or NFATc1/C led to a relatively poor transduc-effect of NFATc1/A or NFATc1/C expression on endoge-
nous NFATc1/A RNA levels in RNase protection assays. tion efficiency between 10%–20%, and the cells showed
a markedly higher spontaneous apoptosis rate of 15%.After induction for 24 hr by TI, a 2- to 5-fold increase
in P1-directed NFATc1/A RNA levels was detected in Whereas stimulation of noninfected T cells or T cells
infected with control virus or NFATc1/A-expressing viruscells expressing either NFATc1/A or c1/C compared to
control cells (compare lanes 5, 10, and 15 in Figure showed the same increase in apoptosis to about 40%
of cells, those infected with NFATc1/C- or NFATc2-6I). All these results indicate that NFAT proteins control
NFATc1/A expression. expressing virus showed a strong increase in apoptosis
rate between 70%–80%. Of note, uninfected cells of
the same assay appeared also to be killed by fratricideIn Contrast to NFATc2 and NFATc1/C, NFATc1/A Does
(Figures 7B and 7C). This indicates that in contrast toNot Promote Apoptosis of T Effector Cells
NFATc2 and NFATc1/C, the short NFATc1 isoform AWe and others have shown previously that NFATc2-
deficient T cells show a delayed AICD (Schuh et al., does not enhance apoptosis of effector T cells, although
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in infected cells it is expressed at a level that is the binding of transcription factors to promoter DNA and
facilitates the binding of other proteins, e.g., of MeCP1same as or even higher than NFATc1/C or NFATc2, re-
spectively (Figure 7D). and MeCP2, which repress transcription by recruiting
histone deacetylases (Boyes and Bird, 1992; Nan et al.,
1998). DNA methylation also contributes to the inactiva-Discussion
tion of tumor suppressor genes by blocking transcrip-
tion from one allele (see Momparler and Bovenzi, 2000).In this study we show that in effector T cells NFAT tran-
For NFATc2, a suppressor function in the generationscription factors autoregulate and enhance the massive
of tumor-like chrondrocytes was postulated studyinginduction of the short isoform A of NFATc1 which, in
NFATc2-deficient mice (Ranger et al., 2000). The inser-marked contrast to NFATc1/C, NFATc2, and NFATc3
tion of the aggressive retrovirus SL3-3 (Sorensen et al.,proteins, is unable to promote apoptosis. This mecha-
1996) into the NFATc1 promoter region (Figure 1C) leadsnism appears to be a survival strategy of effector T
to T cell lymphomas and NFATc1 suppression (S.C. andcells for synthesis of lymphokines and other effector
A.B. Sorensen et al., unpublished data), suggesting thatmolecules before dying by AICD.
NFATc1 might exert a similar function in the generation
of lymphoid tumors.Structure and Expression of the Chromosomal
The two DNase I hypersensitive chromatin sites HSS1Murine NFATc1 Gene
and HSS4, which were detected at P1 or P2, respec-Due to the alternative usage of two promoters and poly
tively, appear to be generated after stimulation of pri-A sites, three prominent NFATc1 isoforms are expressed
mary lymphocytes, probably following hypomethylationin T cells which differ mainly in the length of their
of promoter DNA. In EL-4 thymoma cells, both HSS1C-terminal peptides. As presented in Figure 8, the induc-
and HSS4, along with two additional intronic sites, HSS2tion of NFATc1/A, the most abundant NFATc1 isoform
and HSS3, are constitutively accessible to DNase I (Fig-in effector T cells, is directed by the strong promoter
ures 3A and 3B), indicating an open chromatin confor-P1 and a proximal poly A site, pA1, which is located
mation of NFATc1 promoter region in these cells. Whiledownstream of exon 9. Contrary to the pA2 DNA se-
the function of HSS2 region in NFATc1 expression re-quences following exon 11 that are highly conserved
mains unknown, HSS3 harbors a transcriptional en-between mouse and man, those around pA1 in intron 9
hancer which can support P1 induction (Figure 3C).differ between both species. This suggests conspicuous
Two lines of evidence indicate that numerous, albeitdifferences in the poly A addition at pA1 between human
not all, properties for the strong induction of NFATc1and mouse, and, in fact, the 3 ends of murine and
gene are located within the P1 core promoter of 800human NFATc1/A RNAs differ markedly in their lengths
bp. These are (1) the strong conservation of P1 DNA(Pan et al., 1997; Sherman et al., 1999; Kawai et al.,
between mouse and human (Figure 6A) and (2) transfec-2001; D.T. et al., unpublished data). However, in spite
tion studies (Figure 5A) which show that longer 5 DNAof these variations in 3 end formation, the functional
fragments spanning up to 5.5 kb DNA promote transcrip-collaboration between P1 and pA1 for the generation of
tion as strong as the 800 bp P1 fragment. Among theNFATc1/A is conserved between mouse and human,
transcription factors binding to and controlling P1, sev-indicating the functional importance of this mechanism.
eral have been described to control promoters of otherIn contrast to NFATc1/A, RNA synthesis of the longer
lymphoid-specific genes, such as NF-B, NFAT, SP-1/isoforms, NFATc1/B and C, can be directed either by
SP-3, and Fos (for review see Kuo and Leiden, 1999).promoter P1 or promoter P2, but it is always controlled
The collaboration between all these factors creates aby the strong distal poly A site, pA2 (Figure 8). The
P1 activity which resembles that of promoters of Th2-preferential use of pA1 upon activation of effector T cells
type IL-4 and IL-5 genes but differs markedly from theprevents the synthesis of NFATc1/BC in these cells.
activity of the IL-2 promoter (Figure 5). Remarkably, itInstead, they are the most abundant NFATc1 proteins
also differs from the induction of the endogenousin naive and resting effector T cells (Chuvpilo et al.,
NFATc1 gene in EL-4 cells which is strongly induced by1999b). NFATc1/B and C proteins contain either an
TI (Figure 2B) while the same inducers exert a marginalN-terminal peptide of 42 aa encoded in exon 1 or an
effect on P1 (Figure 5B). The strong forskolin effect mightN-terminal peptide of 27 aa encoded in exon 2, and
reflect a strong contribution of P1 on NFATc1 expressionat their C termini they harbor either the short 128 aa
in Th2 cells which contain high cAMP concentrationsC-terminal peptide of isoform B or the longer peptide
and express NFATc1 at a high level. All this indicatesof 246 aa typical for isoform C, which represents a weak
that (1) the chromosomal context and/or (2) additionaltransactivation domain (Chuvpilo et al., 1999a, 1999b).
transcription factors binding to sequence elements lo-
cated outside the promoter region contribute to NFATc1Structure and Function of the NFATc1 Promoters
induction in T cells.The NFATc1 promoters P1 and P2 are characterized by
the generation of DNase I hypersensitive chromatin sites
and are embedded in CpG islands. Our methylation Autoregulation of NFATc1/A Synthesis
by NFAT Factorsstudies show that P1 is hypermethylated in cells where
NFATc1 is not expressed, such as in kidney cells, and NFAT factors control P1 induction by binding to the
tandemly arranged NFAT site, NFATtand, at position650demethylated in effector T cells. This agrees with the
general view that DNA methylation suppressess tran- within the distal homology block of P1 and a weaker
NFAT site, NFAT90, within the proximal P1 promoterscription of numerous tissue-specific genes (Naveh-
Many and Cedar, 1981). CpG methylation blocks the region (Zhou et al., 2002). Both sites differ from numer-
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ous other NFAT sites within lymphokine promoters to data). A1/Bfl-1 is a member of the family of Bcl-2-related
proteins and is known to exert a strong antiapoptoticwhich NFAT binds in concert with AP-1-like factors (for
a recent review see Macian et al., 2001). The latter con- effect upon induction of B cells through B cell and TNF
receptors (Grumont et al., 1999; Zong et al., 1999), simi-tain the consensus sequence 5-caxwGGAAAawxxxg/
aTGAC/GTCAg/tc-3 (where capital letters denote highly lar to Bcl-2 and Bcl-XL whose expression also appears
to be controlled by NFAT factors (Kel et al., 1999). Inand lower case letters denote poorly conserved nucleo-
light of these findings one may assume that the specifictides; w  A or T; x  any nucleotide), which occurs
effect of individual NFAT proteins in apoptosis regula-ten times more frequently in promoters active in T cells
tion might rely on their capability to control the expres-than in other promoters (Kel et al., 1999). NFATtand ap-
sion of both pro- and antiapoptotic genes at the appro-pears also to be a stronger NFAT binding site than the
priate stage of T cell differentiation and activation. Whiledistal IL-2 NFAT site, Pu-bd. However, the binding of
it remains to be shown by more detailed studies howAP-1 to Pu-bd supports NFAT binding (Macian et al.,
the NFAT proteins differ in this respect, our studies pre-2001) while no AP-1-like binding site is located 3 from
sented here and the marked differences in phenotypeNFATtand (and NFAT90). It remains to be shown whether
between NFATc1- and NFATc2-deficient mice in AICDother factors support NFAT binding to NFATtand. In any
control (Hodge et al., 1996; Ranger et al., 1998b; Schuhcase, NFATtand is an important element through which
et al., 1998; Xanthoudakis et al., 1996; Yoshida et al.,NFATs autoregulate P1 induction and NFATc1/A expres-
1998) document that NFAT factors are specific andsion at relatively low NFAT threshold levels.
prominent regulators of genes controlling the AICD ofThe binding of NFATc1 and NFATc2 to NFATtand (Figure
T effector cells.6B) suggests that NFATc1/A induction is controlled by
both factors. Whereas our cotransfection experiments
Experimental Procedures(Figures 6G and 6H) indicate that NFATc1 protein en-
hances P1 activity and NFATc1/A expression, the tre- Cells and DNA Transfections
mendous increase in NFATc1/A (but not in NFATc1/ All lymphoid cells were grown to a density of 2  105 cells/ml in
RPMI medium containing 5% fetal calf serum (FCS). They wereBC) levels in T cells double-deficient for NFATc23
induced with TPA (20 ng/ml), ionomycin (0.5	M), or TPAionomycin(Ranger et al., 1998c) suggests that NFATc2 (and c3)
(TI) as indicated. In transient transfections of murine EL-4 T lym-inhibits—directly or indirectly—P1 activity. It is presently
phoma cells, 10 	g DNA was transfected into 2.5  107 cells using
unknown how both types of NFAT factors execute this a conventional DEAE-dextran transfection protocol. Mean values of
apparent divergent activity on P1 induction and three transfection experiments are shown. For the differentiation of
NFATc1/A expression. naive CD4CD62Lhi murine T cells in vitro, naive T cells were isolated
from the spleens of BALB/cA mice using CD4 and CD62L Abs
coupled to Dynabeads (Dynal, Hamburg, Germany). The cells wereNFAT Proteins and AICD of T Lymphocytes
stimulated with TCR (2.5 	g/ml) and CD28 Abs (5 	g/ml) and
The observation that the short isoform NFATc1/A which incubated in Iscove’s medium for 3 days. For Th1 differentiation
lacks the C-terminal peptide of approximately 245 aa they were incubated with IL-12 (1000 U/ml), IL-2 (10 ng/ml), and
IL-4 Abs (10 	g/ml) and, for Th2 differentiation, with IL-4 (1000 U/typical for NFATc1/C and NFATc2 does not support
ml) and IFN Abs (10 	g/ml). After addition of IL-2, the cells wereAICD as do other NFATs suggests that this C-terminal
incubated for a further 4 days. The resulting Th1 and Th2 cellspeptide plays an important role in inducing apoptosis
were stimulated for 5 hr with TI or TCR  Abs as describedrelevant genes. For NFATc1/C and NFATc2, it has been previously (Chuvpilo et al., 1999b).
shown that their C-terminal peptide harbors a transacti-
vation domain, TAD-B (Chuvpilo et al., 1999a; Luo et al., Antibodies
The following Abs were used for lymphocyte activation in EMSA,1996b), which, however, appears to be markedly weaker
FACS, and Western blot assays. For T cell stimulation, 5 	g/mlthan the strong N-terminal transactivation domain, TAD-A,
plate-bound CD3
 mAb (145-2C11; cells kindly provided by J.A.that is common to all NFATs (Avots et al., 1999). In other
Bluestone) and 10 	g/ml CD28 mAb (37.51; BD PharMingen) were
studies it has been shown that NFATc2 binds via its used; for AICD induction, CD3
 mAb or Fas (CD95) (Jo2; BD
C-terminal peptide to the N-terminal region of the myo- PharMingen) were used. Annexin staining was performed using
cyte enhancer factor (MEF) 2D (Youn et al., 2000) which Annexin V-PE (BD PharMingen). For NFAT detection, the mAb 7A6
(Northrop et al., 1994) (ABR, MAR-024) raised against NFATc1 andbinds to two sites within the nur77 promoter and thereby
polyclonal Abs 67.1 and T2B1 raised against NFATc2 (kindly pro-controls its activity (Woronicz et al., 1995). nur77 is an
vided by A. Rao) were used.immediate early gene induced by TCR stimulation that
mediates thymocyte apoptosis. RNase Protection Assays
While it remains to be shown whether nur77 expres- For RNase protection assays, total RNA was extracted using TRIzol
reagent (Life Technologies, Gaithersburg, MD). The RNA was pro-sion is involved in NFAT-mediated control of AICD of
cessed according to PharMingen’s (San Diego, CA) RiboQuant pro-peripheral T cells, the expression of other proapoptotic
tocol using antisense RNA probes to determine transcriptional startNFAT-controlled genes, e.g., of CD95L gene, plays an
sites. For the mapping of transcriptional start sites at promoter P1,
important role in this process (see, e.g., Ranger et al., a 386 bp Kpn I/Sac II fragment of 8.65 kb XbaI fragment (Figure 2B)
1998c). However, in addition to their effect on proapo- was cloned in PKS and used for the synthesis of an antisense probe.
ptotic genes, NFAT factors appear also to control the For mapping of exon 1 transcripts, a 126 bp fragment was used for
probe synthesis corresponding to the protein coding region of exonexpression of several antiapoptotic genes. Ectopic ex-
1. For mapping of P2 transcripts, a 244 bp NotI/NotI fragment ofpression of NFATc1/A but not of NFATc1/C in EL-4 cells
8.65 kb XbaI fragment was used.led to an increase in RNA levels of the A1 gene, and
two NFAT-motifs within the A1 promoter were identified Mapping of DNase I Hypersensitive Chromatin Sites
as NFAT binding sites in EMSAs using nuclear proteins The mapping of DNase I hypersensitive chromatin sites was per-
formed according to slightly modified protocols published pre-from induced EL-4 cells (F. B.-S. et al., unpublished
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viously (Agarwal and Rao, 1998; Cockerill, 2000). 32P-labeled PCR Received: December 18, 2001
Revised: May 9, 2002products of approximately 350 bp from the 5 and 3 termini of XbaI
promoter segment (Figure 1C) were used as probes in Southern
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